Nitric oxide-dependent CYP2B degradation is potentiated by a cytokine-regulated pathway and utilizes the immunoproteasome subunit LMP2

Biochemical Journal

Volumn 445, Issue 3, 2012, Pages 377-382

  Sun, Haiyan ^a,b   Lee, Choon Myung ^a   Tripathi, Shweta ^a   Kim, Kyung Bo ^c   Morgan, Edward T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHENZHEN POLYTECHNIC   (China)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cytochrome P450; Immunoproteasome; Interleukin 1 (IL 1); Nitric oxide (NO); Proteasome

Indexed keywords

CYTOCHROME P450 2B; CYTOKINE; INTERLEUKIN 1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PEPTIDASE; PROTEASOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DEGRADATION; DOWN REGULATION; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SUBUNIT; RAT;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CYSTEINE ENDOPEPTIDASES; CYTOCHROME P-450 CYP2B1; GENES, TUMOR SUPPRESSOR; HEPATOCYTES; INTERLEUKIN-1; KINETICS; MALE; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE II; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, INBRED F344; STEROID HYDROXYLASES;

RATTUS;

EID: 84864375023     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120820     Document Type: Article

References (35)

1. Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E. and Chaudhuri, G. (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 84, 9265-9269
2. Palmer, R. M., Ferrige, A. G. and Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524-526 (Pubitemid 17085822)
3. Moncada, S., Palmer, R. M. and Higgs, E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142
4. Hirst, D. G. and Robson, T. (2011) Nitric oxide physiology and pathology. Methods Mol. Biol. 704, 1-13
5. Koeck, T., Fu, X., Hazen, S. L., Crabb, J. W., Stuehr, D. J. and Aulak, K. S. (2004) Rapid and selective oxygen-regulated protein tyrosine denitration and nitration in mitochondria. J. Biol. Chem. 279, 27257-27262 (Pubitemid 38812564)
6. Foster, M. W., Hess, D. T. and Stamler, J. S. (2009) Protein S-nitrosylation in health and disease: a current perspective. Trends Mol. Med. 15, 391-404
7. Gaston, B. M., Carver, J., Doctor, A. and Palmer, L. A. (2003) S-nitrosylation signaling in cell biology. Mol. Interv. 3, 253-263
8. Miersch, S. and Mutus, B. (2005) Protein S-nitrosation: biochemistry and characterization of protein thiol-NO interactions as cellular signals. Clin. Biochem. 38, 777-791 (Pubitemid 41097484)
9. Li, F., Sonveaux, P., Rabbani, Z. N., Liu, S., Yan, B., Huang, Q., Vujaskovic, Z., Dewhirst, M. W. and Li, C. Y. (2007) Regulation of HIF-1α stability through S-nitrosylation. Mol. Cell 26, 63-74 (Pubitemid 46550936)
10. Azad, N., Vallyathan, V., Wang, L., Tantishaiyakul, V., Stehlik, C., Leonard, S. S. and Rojanasakul, Y. (2006) S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation. A novel antiapoptotic mechanism that suppresses apoptosis. J. Biol. Chem. 281, 34124-34134 (Pubitemid 46036621)
11. Kim, S., Wing, S. S. and Ponka, P. (2004) S-nitrosylation of IRP2 regulates its stability via the ubiquitin-proteasome pathway. Mol. Cell. Biol. 24, 330-337 (Pubitemid 38010058)
12. Wei, W., Li, B., Hanes, M. A., Kakar, S., Chen, X. and Liu, L. (2010) S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis. Sci. Transl. Med. 2, 19ra13
13. Strehl, B., Seifert, U., Kruger, E., Heink, S., Kuckelkorn, U. and Kloetzel, P. M. (2005) Interferon-γ, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing. Immunol. Rev. 207, 19-30 (Pubitemid 41415005)
14. Schwartz, A. L. and Ciechanover, A. (2009) Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu. Rev. Pharmacol. Toxicol. 49, 73-96
15. Jariel-Encontre, I., Bossis, G. and Piechaczyk, M. (2008) Ubiquitin-independent degradation of proteins by the proteasome. Biochim. Biophys. Acta 1786, 153-177
16. van Deventer, S. and Neefjes, J. (2010) The immunoproteasome cleans up after inflammation. Cell 142, 517-518
17. Fruh, K. and Yang, Y. (1999) Antigen presentation by MHC class I and its regulation by interferon γ . Curr. Opin. Immunol. 11, 76-81 (Pubitemid 29082341)
18. Seifert, U., Bialy, L. P., Ebstein, F., Bech-Otschir, D., Voigt, A., Schroter, F., Prozorovski, T., Lange, N., Steffen, J., Rieger, M. et al. (2010) Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142, 613-624
19. Niwa, T., Murayama, N. and Yamazaki, H. (2009) Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome. Curr. Drug Metab. 10, 700-712
20. Nebert, D. W. and Dieter, M. Z. (2000) The evolution of drug metabolism. Pharmacology 61, 124-135
21. Chen, Y. and Goldstein, J. A. (2009) The transcriptional regulation of the human CYP2C genes. Curr. Drug Metab. 10, 567-578
22. Plant, N. (2007) The human cytochrome P450 sub-family: transcriptional regulation, inter-individual variation and interaction networks. Biochim. Biophys. Acta 1770, 478-488
23. Correia, M. A., Sadeghi, S. and Mundo-Paredes, E. (2005) Cytochrome P450 ubiquitination: branding for the proteolytic slaughter? Annu. Rev. Pharmacol. Toxicol. 45, 439-464 (Pubitemid 40261813)
24. Faouzi, S., Medzihradszky, K. F., Hefner, C., Maher, J. J. and Correia, M. A. (2007) Characterization of the physiological turnover of native and inactivated cytochromes P450 in cultured rat hepatocytes: a role for the cytosolic AAA ATPase p97? Biochemistry 46, 7793-7803
25. Ferrari, L., Peng, N., Halpert, J. R. and Morgan, E. T. (2001) Role of nitric oxide in down-regulation of CYP2B1 protein, but not RNA, in primary cultures of rat hepatocytes. Mol. Pharmacol. 60, 209-216 (Pubitemid 32600066)
26. Lee, C. M., Kim, B. Y., Li, L. and Morgan, E. T. (2008) Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins. J. Biol. Chem. 283, 889-898
27. Aitken, A. E., Lee, C. M. and Morgan, E. T. (2008) Roles of nitric oxide in inflammatory downregulation of human cytochromes P450. Free Radical Biol. Med. 44, 1161-1168
28. Lee, C. M., Pohl, J. and Morgan, E. T. (2009) Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures. Drug Metab. Dispos. 37, 865-872
29. Ni, B., Zhou, J., Dong, Y., Peng, J., Wu, X., Li, R., Chen, M., Zhou, C., Tan, Y. and Wu, Y. (2007) Interleukin-1 up-regulates the expression and activity of 26S proteasome in burned rat. Burns 33, 621-627 (Pubitemid 46880037)
30. Ho, Y. K., Bargagna-Mohan, P., Wehenkel, M., Mohan, R. and Kim, K. B. (2007) LMP2-specific inhibitors: chemical genetic tools for proteasome biology. Chem. Biol. 14, 419-430 (Pubitemid 46617320)
31. Parlati, F., Lee, S. J., Aujay, M., Suzuki, E., Levitsky, K., Lorens, J. B., Micklem, D. R., Ruurs, P., Sylvain, C., Lu, Y. et al. (2009) Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome. Blood 114, 3439-3447
32. Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S. and Tannenbaum, S. R. (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126, 131-138 (Pubitemid 13203451)
33. Kotamraju, S., Matalon, S., Matsunaga, T., Shang, T., Hickman-Davis, J. M. and Kalyanaraman, B. (2006) Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells. Free Radical Biol. Med. 40, 1034-1044 (Pubitemid 43376013)
34. Vasuri, F., Capizzi, E., Bellavista, E., Mishto, M., Santoro, A., Fiorentino, M., Capri, M., Cescon, M., Grazi, G. L., Grigioni, W. F. et al. (2010) Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis. Biochem. Biophys. Res. Commun. 397, 301-306
35. Khan, S., van den Broek, M., Schwarz, K., de Giuli, R., Diener, P. A. and Groettrup, M. (2001) Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J. Immunol. 167, 6859-6868 (Pubitemid 33144178)